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Rapid Rounding of Human Epidermoid Carcinoma Cells
A-431 Induced by Epidermal Growth Factor
ABSTRACT
￿
Epidermal growth factor (EGF) induces rapid rounding of A-431 human epidermoid
carcinoma cells in Ca'-free medium . Cell rounding is not induced by a variety of other
polypeptide hormones, antiserum to cell membranes, local anesthetics, colchicine, cytochalasin
B, or cyclic nucleotides. However, trypsin, like EGF, induces rounding of A-431 cells in the
absence of Ca". Both trypsin- and EGF-induced rounding are temperature dependent, appear
to be energy dependent, and are inhibited by cytochalasins, suggesting the active participation
of microfilaments in cell rounding. However, a medium transfer experiment suggests that EGF-
induced rounding is not attributable to secretion of a protease, and a number of serine protease
inhibitors have no effect on the EGF-induced rounding process. Cell rounding is not attributable
to the slight stimulation by EGF of the release of Ca" that is observed in Ca'-free medium,
as stimulation of such release by the ionophore A23187 neither induces cell rounding nor
blocks EGF-induced rounding.
Cells that have rounded up after treatment with EGF or trypsin spread out upon addition of
Ca" to the medium, even in the continuing presence of EGF or trypsin. Like the cell-rounding
process, the cell-spreading process is temperature dependent, appears to be energy dependent,
and is inhibited by cytochalasin B. Thus, EGF does not destroy the ability of the cell to spread;
rather, in the presence of EGF (or trypsin), cell spreading and the maintenance of the flattened
state become dependent on external Ca ++ . Because untreated cells remain flattened in the
absence of Ca++ , the data suggest that EGF may disrupt Ca++ -independent mechanisms of
adhesion normally present in A-431 cells.
Cells grown in monolayer culture may become rounded in
response to a wide variety of substances. These include hor-
mones, cyclic nucleotides (23, 28, 29, 31, 43), proteases (12, 32,
36), and antisera raised against membrane proteins (13, 41, 42).
In addition, cells normally round up during mitosis. Cell
rounding presumably occurs because of reorganization of the
cytoskeleton, but thebiochemical mechanisms leading to such
reorganization are not yet known.
Several recent studies concerned with the mechanism of
action of epidermal growth factor (EGF) have employed the
human epidermoid carcinoma cell line A-431. The unusually
high number of receptors for EGF present on these cells has
facilitated visualization of the binding of EGF and clustering
and endocytosis of the EGF/receptor complex (16, 18, 25), as
well as demonstration of the rapid stimulation of the rates of
fluid pinocytosis in whole cells (19) and protein phosphoryla-
tion in isolated membranes(6, 7) by EGF. In addition, we have
recently reported that A-431 cells undergo a sequence of shape
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changes in response to EGF (8). Within 1 min of exposure to
EGF, numerous ruffles and filopodia are formed. This effect
is transient, peaking at 2 min of treatment, and is followed by
agradual retraction from thesubstrate at the edgesof colonies.
After several hours, the monolayerculture hasreorganized into
multilayered colonies.
This sequence of morphological changes, originally de-
scribed for cells growing in Dulbecco's Modified Eagle's Me-
dium (DMEM) containing serum, may also be observed in
simple buffered saline solutionscontaining millimolar levels of
Ca" (our unpublished observations). However, as reported in
this paper, the omission of Ca" from the medium drastically
alters the morphological response of A-431 cells to EGF. In
Ca'-free medium, EGF induces rapid rounding of A-431
cells. Because this response is easily monitored by phase-con-
trast microscopy, we have been able to investigate the mecha-
nism of EGF-induced cell rounding by observing the effects of
a variety of experimental manipulations on this process.
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Cell Culture
A-431 human epithelioid carcinoma cells were grown in DMEM containing
10% fetal calf serum (FCS) . Cultures were routinely prepared in 35-mm Falcon
culture dishes (Falcon Lobware, Div . of Becton, Dickinson & Co., Oxnard,
Calif.). For SEM, cells were grown on 22-mm square cover glasses in 35-mm
dishes .
Assay for Cell Rounding
Cells were washed once with l ml Dulbecco's phosphate-buffered saline (PBS;
137 mM NaCl, 2.7 mM KCI, 8.0 mM Na2HPO,, 1 .5 mM KH 2PO4 , 0.9 MM
CaC12 , 0.5 MM MgC12), once with l ml Ca"-/Mg'*-free Dulbecco's phosphate-
buffered saline (CMF), and incubated at 25°C in 1.0 mlCMF in the presence or
absence of 100 ng EGFand/or various substances being tested for their effects
on cell rounding . Except where indicated in the text, such substances and EGF
were added to the cultures simultaneously. After 20 min, the living cells were
examined by phase-contrast microscopy . Appropriate controls were run to test
the effects of the solvents in which stock drug solutions were prepared.
Light Microscopy
Routine observations of living cells were made at x 100 on a Wild M40
inverted phase-contrast microscope . Phase-contrast photomicrography of living
cells was performed on a Leitz microscope using a Leitz Orthomat camera and
Kodak PlusX film.
SEM
Cells were fixed for l h with 4% glutaraldehyde in CMF, washed three times
for 10 min each with 0.1Msodium phosphate, pH 7.1, and postfixed for2h with
1% OSO, in 0.1 Msodium phosphate, pH 7.1 . The cultures on cover slips were
then rinsed several times with distilled water, dehydrated through a graded
ethanol series, and critical point dried, using the phase-separation method of
alcohol/CO2 substitution to minimize theeffects ofconvectioncurrentson surface
ultrastructure (26) . Cover slips were cut into quarters, which were mounted on
aluminum stubs with graphite paste and sputter coated with Au/Pd . Fixation,
washing, and dehydration were performed at room temperature.
Samples were viewed on a Hitachi S-500 microscope operated at 20 kV .
KodakMin-R X-ray film, developed with a Kodak RP X-Omat processor, was
used for micrography .
Measurement of Cellular Ca ++ Release
Cells were preincubated for 20 h at 37°C in 2.0 mlDMEM containing 10%
FCSand 2.8 PCi [`CaICaC12 (New England Nuclear, Boston, Mass .) . Cultures
were then washed as described for the standard rounding assay (once with 2 ml
PBS and once with 1 ml CMF) and incubated at 25°C in 1.0 ml CMF in the
presence or absence ofEGF (100 ng/ml) or A23187 (10AM) . After various times,
duplicate cultures were washed rapidly three times with 1.5 ml of ice cold CMF,
bringing the total number ofwashes after loading with "Ca" to six. Remaining
cell-associated radioactivity was determined by solubilizing the cells in 1.0 ml 0.5
N NaOH, mixing with 10 ml ofAquasol(New England Nuclear), and counting
in a liquid scintillation counter (LS-3133P ; Beckman Instruments, Inc., Irvine,
Calif.) . To obtain a value for cell-associated radioactivity at zero time (no
incubation in CMF), cells were treated exactly as described above except that the
"incubation" inCMF at 25°C consisted of only a rapid wash withCMF.
Measurement of Cellular ATP
ATP in perchloric acid extracts of A-431 cells was determined by use of a
firefly luciferase assay (22) .
Materials
Mouse EGF (33) and DEAE-purified antisera to mouse EGF (9, 14) and to
A-431 cell membranes (17) were prepared as previously described. The A-431
cell line was obtained from Dr. J . DeLarco, National Institutes of Health .
RESULTS
EGF-induced Rounding
Rapid cell rounding occurs when monolayer cultures of A-
431 cells are treated with EGF in Ca'-free media. This
phenomenon is illustrated in Fig. 1, using phase-contrast mi-
croscopy of living cells . A-431 cells incubated for 20 min at
FIGURE 1
￿
Effect of EGF on A-431 cell shape in the presence or absence of Ca". Phase-contrast micrographs of living cells at x
160 . All incubations were for20 min at 25 °C. (A) Incubation in CMF . Cells remain flattened . (B) Incubation in CMF containing 100
ng/ml EGF. Cells are rounded . (C) Incubation in CMF supplemented with 1 mM CaC12 . (D) Incubation in CMF supplemented
with 1 mM CaC12 and 100 ng/ml EGF. No cell rounding has occurred in the presence of Ca" .




42325°C in Ca"-/Mg*'-free CMF remain flattened (Fig . 1 A) .
However, when EGF (100 ng/ml) is present during such an
incubation, most cells become highly rounded (Fig. 1 B) . This
phenomenon occurs only in the absence of added Ca" ; in the
presence of 1 mM Ca", A-431 cells remain flattened in either
the absence (Fig . 1 C) or the presence (Fig. 1D) ofEGF . Thus,
it appears that eitherCa" inhibits EGF-induced rounding, or
the absence of Ca" permits EGF to have this effect . In
contrast, EGF-induced rounding may occur in the presence of
I MM Mg" .
The observations have been confirmed and extended by use
ofscanning electron microscopy (Fig . 2) . Untreated A-431 cells
(Fig . 2A) are flattened and covered with small plicae, as
previously described (8) . The cells have a similar, though
somewhat less flattened, appearance after a 20-min incubation
in CMF (Fig . 2B) . After 20 min in CMF containing EGF, the
FIGURE 2
￿
EGF-induced rounding of A-431 cells . (A) Untreated culture . Cells are flattened and display many plicae . (B) Culture
incubated in CMF for 20 min at 20°C . Cells have contracted slightly . (C) Culture incubated for 10 min at 25°C in CMF containing
100 ng/ml EGF. Large ruffles and filopodia may be observed . (D) Incubation for 20 min at 25°C in CMF containing 100 ng/ml EGF.
Cells are rounded and display many blebs and retraction fibers . Scanning electron micrographs at x 1,400.
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substrate and to each other by retraction fibers (Fig. 2D).
Partly rounded cells (Fig. 2C, 10-min treatment with EGF in
CMF) may display large ruffles and filopodia. Stimulation of
ruffle and filopodium formation by brieftreatment with EGF
in the presence of Ca" has previously been reported (8).
Whether A-431 cells respond to EGF by rapidly rounding
or by rapidly ruffling and gradually retracting and piling up
on one another as described previously (8) depends only on
the absence or presence of Ca". The other differences in
incubation conditions (37°C in DMEM + 10% serum in the
previous report vs. 25°C in PBS in the experiments described
herein) have little effect on the morphological response. That
is, EGF induces A-431 cell rounding either in CMF at 25'C or
in DMEM containing 10% serum and 2 mM EDTA at 37°C,
whereas the previously reported ruffling/retraction/piling up
sequence occurs either in Ca++-containing PBS at 25°C or in
DMEM containing 10% serum at 37°C.
Experiments were performedto determine the concentration
of EGFrequired to produce optimalcell rounding. Concentra-
tions of EGF as low as 5 ng/ml caused complete rounding of
many cells, but at least 50 ng/ml was required to produce
rounding of nearly allcells in a culture. This suggests that some
variability exists among A-431 cells with regard to responsive-
ness to EGF. For our standard rounding assay (see Materials
and Methods) we selected an EGF concentration (100 ng/ml)
that reproducibly yielded rounding of virtually all of the cells
in a culture during a 20-min incubation in CMF at 25°C.
The responses illustrated in Figs. 1 and 2 were typical;
however, in several experiments unknown factors resulted in
significant cell rounding in CMF in theabsence of EGF. Even
in these experiments, however, the relative effect of EGF was
apparent because the CMF + EGF-treated cells were much
more rounded than those treated with CMF only.
Specificity of the EGF Effect
To test the specificity of the rounding effect of EGF on A-
431 cells, we substituted the following polypeptide hormones
for EGF in the cell-rounding assay: insulin, glucagon, follicle-
stimulating hormone (FSH), thyrotropin, growth hormone,
prolactin (all at 67 Ag/ml), or fibroblast growth factor (133 ng/
ml). Neithera20-min incubation with these hormones in CMF
at 25°C nor a 1-h incubation at 37°C had any effect on the
shape of the A-431 cells as visualized by phase-contrast mi-
croscopy.
Although this experiment established that themere presence
ofavariety ofpeptidehormones wouldnotcausecell rounding,
we do not know whether A-431 cells bind any of the above
hormones. Therefore, we tested the ability of concanavalin A
(Con A) and of antiserum to A-431 membranesto producecell
rounding. Because both of these substances block the binding
of EGFto its receptor (5, 17), they presumably bind at or near
the EGF binding site. Incubation with Con A (1001íg/ml) or
DEAE-purified antiserum to A-431 membranes (160 hg/ml)
for 20 min at 25°C or 1 h at 37°C did not produce any cell
rounding. Thus, the effect of EGF on A-431 cell shape appears
to be highly specific.
Role of Ca ++
Because EGF induces cell rounding only in the absence of
added Ca", it seemed possible that the rounding might be
caused by leakage of Ca" from the cells, andthat this leakage
might be accelerated by treatment with EGF. This hypothesis
was tested by preloading cells with
45Ca" and measuring the
loss of cell-associated radioactivity under standard rounding
conditions (Fig. 3). Although EGF may cause a slight stimu-
lation of Ca" efflux, it is unlikely that this is the cause of cell
rounding, becausestimulation of Ca"efflux by the ionophore
A23187 (Fig. 3) did not produce cell rounding during a20-min
incubation at 25°C. Similarly, treatment with EGTA (1 mM),
which would be expected to accelerate Ca" efflux, did not
mimic treatment with EGF in the rounding assay. Thus, the
mere loss of cellular Ca' appears to be insufficient to cause
rounding. Although it could be hypothesized that A23187
causes a flux of Ca"similar to that caused by EGF, plus other
changes that block rounding, this seems unlikely, as A23187
does not block the rounding induced by EGF. The ionophore
neithercaused nor blocked cell rounding at doses rangingfrom
10 nM to 10 p,M.
Displacement of Ca" from the plasma membrane hasbeen
suggested as a mechanismwhereby local anesthetics induce the
rounding of some cell types(30). Therefore, we tested lidocaine
(1 mM, 5 mM), procaine (1 mM, 10 mM), cocaine (1 mM, 10
mM), and tetracaine (0.1 mM, 1 mM) in thestandard rounding
assay. None were able to produce appreciable rounding of A-
431 cells, again attesting to the specificity ofthe EGF-induced
morphological alterations.
Metabolic Activity and Cell Rounding
To investigate thepossible involvement ofcellular metabolic
activity in the EGF-induced rounding process, we examined
the effects ofmetabolic inhibitors on cell rounding.
Uncouplers of oxidative phosphorylation were used to in-
vestigate the ATP requirements of the rounding process. Cel-
lularATP levels were reduced by preincubatingcultures for 15
min at 37°C in PBS containing Ca" and Mg" and 5 x 10-"
Mazide or 5 x 10-5 M 2,4-dinitrophenol (Table 1). The treated






















FIGURE 3 Effect of EGF on the release of Ca" from A-431 cells
during incubation in CMF. Cells were preloaded with °SCa and
assayed for the release of Ca" as described in Materials and
Methods. Counts are expressed as a percentage of cell-associated
counts at t = 0 (6,300 cpm) . O, control; x, EGF (100 ng/ml) ; O,
A23187 (10 pM).




425and Methods, adding fresh azide or dinitrophenol simultane-
ously with the EGF . In contrast to the results obtained under
our standard conditions, no cell rounding was observed during
a 20-min incubation at 25°C (Fig . 4A) . However, the addition
TABLE I
Effects of Energy Inhibitors on ATP Levels in A-431 Cells
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glucose
A-431 cells, at ^-7.5 x 108 cells per100-mm dish, were treated as indicated in
duplicate and the cell monolayers were extracted on ice with 3 ml of cold 0.5
N perchloric acid . Concentrations of reagents were : 2,4-dinitrophenol, 5 x
10-5M; sodium azide, 5x 10-`M; EGF, 100 ng/ml ; glucose, 1 mg/ml ; NaF, 10
mM Rounding assays and determination of ATP in perchloric acid extracts
were performed as described in Materials and Methods.
of glucose (1 mg/ml) to the medium at the end of this 20-min
incubation resulted, after a further 20 min, in cell rounding in
the EGF-treated cultures (Fig. 4B) ; upon the addition of
glucose, cellular ATP concentrations returned to control levels
(Table I) . Rounding was prevented ifthemedium was adjusted
to contain 10 mM NaF at the time of addition of glucose (not
shown); the presence ofNaF further lowered the cellular ATP
level and prevented the glucose-induced increase (Table I) .
These data suggest that uncouplers of oxidative phosphory-
lation may block EGF-induced cell rounding in the glucose-
free CMF medium by partially depleting cellular ATP . It is
puzzling that the uncouplers blocked cell rounding under
conditions in which ATP levels were reduced by only 30-40% ;
this raises the possibility that dinitrophenol and azide block
rounding through side effects unrelated to inhibition of ATP
production . However, this seems unlikely for two reasons : (a)
lowering cellular ATP levels with either of two structurally
unrelated inhibitors blocks cell rounding, and (b) raising and
lowering ATP levels by several means correlates with permis-
sion or prohibition, respectively, of EGF-induced cell round-
ing. Lowering ATP with dinitrophenol or azide blocks round-
ing . Adding glucose to the medium permits cell rounding and
concurrent regeneration, presumably through glycolysis, of
ATP, even in the continued presence ofthe uncouplers . Finally,
the glycolytic inhibitor NaF prevents the glucose effects on
both cell rounding and ATP regeneration .
The effect of temperature on the EGF-induced rounding
process was examined . A-431 cells treated with EGF (100 ng/
ml) in CMF rounded up within 20 min of addition of the
hormone to the medium at 25°C and within 10 min at 37°C .
At 0°C, however, the same treatment produced no cell round-
ing during a 2-h incubation, as observed by phase-contrast
FIGURE 4
￿
Inhibition and reversal of EGF-induced rounding . (A) Cells incubated for20 min in CMFcontaining 100 ng/ml EGF and
50p,M 2,4-dinitrophenol . Cells remain flattened . (B) Aftertreatment as in A, glucose (1 mg/ml) was added to the medium andthe
cells were incubated for 20 min. Cells are rounded . (C) Incubation in CMF containing 100 ng/ml EGF and 10 hg/ml cytochalasin
B . Cell rounding is partially inhibited . (D) After a 20-min incubation in CMF containing 100 ng/ml EGF, 1 mM CaC12was added to
the rounded cells . After a further 30-min incubation, most of the rounded cells have spread . All incubations at 25 °C. Phase-




A. None 58.5 t 2.2
B . 15-min preincubation at 37°C in PBS 62 .1 ± 2.9
C . 15-min preincubation at 37 °C in PBS containing 35 .1 ±2.2
dinitrophenol
D. 15-min preincubation at 37°C in PBS containing 43 .8 ± 1 .4
azide
E . As C but further incubated at 25 °C for 20 min in 61 .2 ± 2.8
CMF containing dinitrophenol and EGF
(rounding assay) followed by addition of glu-
cose for 20 min at 25°C .
F . As E except NaF added simultaneously with glu- 1.5 t0.1
cose
G. As D but furtherincubated at 25°Cfor20 min in 63.0 ± 1 .6
CMF containing azide and EGF (rounding as-
say) followed by addition of glucose for 20
min at 25 °C.
H. As G except NaF added simultaneously with 7.8 ±0.1microscopy, even though A-431 cells are known to bind EGF
at 0 °C (16, 18, 19). The temperature dependence ofthe round-
ing process provides additional evidence that metabolic activ-
ity, or perhaps membrane fluidity, is required for this process.
The possible role ofprotein synthesis in the rounding process
was then examined. Cycloheximide (20 pg/ml) does not block
EGF-induced cell rounding in the standard rounding assay,
although the incorporation of amino acids into TCA-precipi-
table materials is inhibited >95% under these conditions (data
not shown). Thus, although certain metabolic activities seem
necessary for cell rounding (above), protein synthesis does not
appear to be required.
Role of Microtubules and Microfilaments in the
Cell-rounding Process
Because microtubules and microfilaments are known to be
involved in the control of cell shape, the role ofthese structures
in the EGF-induced rounding process was studied, using col-
chicine and cytochalasin B.
Because rounded cells may contain fewer or less well orga-
nized microfilaments and microtubules (15, 21, 24, 40), we first
tested the hypothesis that A-431 cells would round up afterthe
disruption of these structures. However, colchicine (10-5 M),
cytochalasin B (10 pg/ml), and the combination of the two
drugs were all unable to induce A-431 cell rounding in the
standard rounding assay. This result suggests that disruption
of microtubules and/or microfilaments is insufficient to cause
rounding of A-431 cells, and, therefore, that EGF does not act
by such a disruptive mechanism.
We next tested the ability of these drugs to inhibit EGF-
induced cell rounding. Cytochalasin B inhibits EGF-induced
rounding (Fig. 4 C), suggesting that intact actin-containing
microfilaments play an important role in the EGF-induced
rounding process. Identical results were obtained using cyto-
chalasin A, D, or E. Colchicine had no effect on the rounding
process under standard assay conditions, even if the cultures
were preincubated with the drug for 2 h and then assayed for
rounding in the presence of EGF and colchicine.
Reversibility of EGF-induced Rounding
The following experiments were performed to examine the
conditions under which cells, rounded in the presence of EGF,
could regain a flattened morphology.
Because rounding occurs only in the absence of Ca", we
tested the ability ofCa" to reverse the rounding process. Cells
were rounded by treatment with EGF (100 ng/ml) in CMF for
20 min at 25°C. Rounding was monitored by phase-contrast
microscopy. After this 20-min incubation, CaC12 was added to
the medium to a final concentration of 1 mM. Within 40 min
of addition of Ca" at 25°C, most of the EGF-rounded cells
were once again well-flattened (Fig. 4D). Thus, the EGF-
induced rounding process is reversiblesimply upon addition of
Ca" to the medium, even in the continuous presence of EGF.
This cell-spreading process, like the EGF-induced rounding
process, appears to be energy dependent. If cells were treated
as described in the preceding paragraph except that the medium
was adjusted to contain 5 X 10-" M azide or 5 X 10-5 M 2,4-
dinitrophenol immediately before the addition ofCa", no cell
spreading was observed after a 40-min incubation at 25°C in
the presence of Ca". However, if 1 mg of glucose was added
to each culture after this 40-min incubation, the cells spread
out within another 40 min at 25°C. Adjusting the medium to
contain 10 mM NaF immediately before the addition ofglucose
prevented cell spreading. NaF did not block cell spreading in
the absence of the uncouplers. For reasons similar to those
discussed above with regard to the effects of azide and dinitro-
phenol on EGF-induced rounding, it appears that ATP pro-
duction is required for the spreading process.
Like EGF-induced rounding, cell spreading does not appear
to require protein synthesis. If cells are rounded by treatment
with EGF (100 ng/ml) in CMF at 25°C, subsequent addition
of both cycloheximide (20 pg/ml) and 1 mM CaC12 to the
medium permits cell spreading to occur at the same rate as
when CaC12 alone is added.
Cell spreading is largely blocked by adding cytochalasin B
(10 pg/ml) to the medium at the time of Ca" addition, but not
by adding colchicine (10-5 M). Spreading does not occur at
0°C.
Thus, the pharmacological sensitivities of the cell-spreading
process are similar ifnot identical to those ofthe EGF-induced
rounding process. Both processes are temperature dependent,
appear to be energy dependent, and are cytochalasin sensitive;
neither are affected by cycloheximide or colchicine. Both cell
spreading and cell rounding appear to be active processes that
involve the system of actin containing microfilaments.
Protease-induced Rounding of A-431 Cells
Because proteases such as trypsin are known to induce cell
rounding (12, 32, 36), we investigated the possible role of
proteases in the EGF-induced rounding process.
Like EGF, trypsin (5 pg/ml) causes A-431 cells in CMF to
round up within 20 min at 25°C. In experiments identical to
those described above for EGF-induced rounding, it was de-
termined that trypsin-induced rounding may be blocked or
reversed by 1 mM Ca". In addition, the trypsin-induced
rounding process is reversiblyinhibited by azide or dinitrophe-
nol, and is partially blocked by cytochalasin B, as determined
in experiments identical to those with EGF. Thus,a number of
similarities exist between the rounding processes induced by
EGF and trypsin.
The possibility that EGF causes cell rounding by stimulating
secretion of a protease was examined by a medium-transfer
experiment. Cells were rounded up by treatment with 100 ng
EGF in 1 ml CMF for 20 min at 25°C. EGF in the medium
was then inactivated by addition of an excess (1 .4 mg) of
DEAE-purified antiserum to EGF. This medium was then
transferred to a dish ofuntreated cells. However, this medium
from EGF-treated cells did not cause cell rounding, as moni-
tored by phase-contrast microscopy. In a control experiment,
DEAE-purified serum (1.8 mg) was used in place of anti-EGF;
this control medium was able to stimulate rounding in a fresh
dish of cells, presumably by virtue of the EGF present. This
experiment suggests that EGF-induced rounding is not medi-
ated by a secreted protease, but it does not rule out the
involvement of a cell-associated protease in the rounding proc-
ess.
However, experiments using inhibitors of serine proteases
suggest that EGF-induced rounding is not mediated by such
an enzyme. Soybean trypsin inhibitor (1 mg/ml), bovine pan-
creatic trypsin inhibitor (1 mg/ml), N-ap-tosyl-L-lysine chlo-
romethyl ketone (10 pg/ml), L-1-tosylamide-a-phenylethyl
chloromethyl ketone (10 pg/ml), phenylmethylsulfonyl fluo-
ride (1 mM), and p-nitrophenyl-guanidobenzoate (0.5 mM) all
failed to inhibit the EGF-induced rounding process in the cell
rounding assay.




427In summary, although fundamental similarities may exist
between EGF-induced andprotease-induced cell rounding, no
evidence has been obtained indicating that EGF-induced
rounding involves the action of a protease.
Lack of Effect of Cyclic Nucleotides on
Cell Rounding
Because cyclic nucleotides have been reported to induce
flattening (21, 39) or rounding (23, 28, 29, 31, 43) of cells
growing in tissue culture, we investigated the possibility that
EGF caused cell rounding by altering cyclic nucleotide levels.
We tested the effectsof the 8-bromoderivatives of cyclic AMP
and cyclic GMP at concentrations of 0.1 mM and 1 mM, using
our standard rounding assay. These substances neithercaused
cell rounding nor blocked EGF-induced cell rounding, as
observed by phase-contrast microscopy after a 20-min incu-
bation at 25°C. Identical results were obtained when the cyclic
nucleotide analogues were tested in the presence of the cyclic
nucleotide phosphodiesterase inhibitor methyl isobutylxan-
thine (1 mM). Thus, it appears unlikely that cyclic nucleotides
are involved in the rounding response to EGF.
DISCUSSION
EGF induces rapid morphological changes in A-431 human
epidermoid carcinoma cells in monolayer culture. Although
thefinalcell shapeobtained aftertreatment with EGF depends
on whetheror not Ca" is present in the medium, ruffling and
then retraction from the substrate are observed within minutes
of addition of EGF to the medium in either thepresence (8) or
theabsenceof Ca". In the absenceof Ca", rapidcell rounding
is then observed, whereas in the presence of Ca", a more
complex series ofmorphological changes ensues (8).
Because EGF inducesrapidcell rounding only in the absence
of Ca", therole ofCa" in this process is ofinterest. Rounding
does not appear to be the result of a Ca" flux, as the Ca"
ionophore A231ß7 can neither cause cell rounding nor block
it. Treatment of A-431 cells with EGF may result in decreased
cellular adhesiveness to thesubstratesuch that maintenanceof
a flattened state becomes increasingly dependent on extracel-
lular Ca". This loss of adhesiveness might account for the
gradual retraction from the substrate observed even in the
presence ofCa", andfortherapidrounding observed in Ca"-
free medium. This possibility is further supported by the ob-
servation that A-431 cellstreated with EGF in the presence of
Ca" are more prone to artifactual detachment during extrac-
tion with detergent or processing forelectron microscopy than
are untreated cells.
It is of interest to compare our results with thoseofLawrence
et al. (23), who reported that treatment of cultured ovarian
granulosacells with FSH led to cell rounding after 1 hat 37 °C.
Although this cell rounding process resembles the EGF-in-
duced rounding of A-431 cells in its apparent requirement for
ATP and itsindependence ofprotease action, proteinsynthesis,
Ca" fluxes, and microtubule function, the responses differ in
several important respects: (a)Unlike EGF-inducedrounding,
FSH-inducedrounding mayoccurin thepresence of Ca". (b)
FSH-induced rounding may be mimicked by treatment with
cytochalasin B, Cytochalasin B inhibits EGF-induced round-
ing. (c) Cyclic AMP, which appears to mediate FSH-induced
rounding of granulosa cells, appears to be uninvolved in the
EGF-induced rounding of A-431 cells. Thus, although these
hormones may producegrossly similar morphological changes
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in their target cells, their mechanisms of action seem quite
different.
Carpenter et al. (6, 7) have reported that EGF rapidly
stimulates phosphorylation of isolated A-431 membranes by
an endogenous cAMP-independent protein kinase. We specu-
late that a phosphorylation event may be responsible for the
morphological alterations induced by EGF. It may also be
speculated that in systems in which cell rounding is mediated
by cAMP, cAMP-dependent protein kinases may be involved.
The hypothesis that morphological changes may be induced
by changes in the state of phosphorylation of cytoskeletal
proteins is consistent with the energy dependence of the shape
changes discussed above, as well as with observations that
differentstates of phosphorylation ofspectrin relate to changes
in erythrocyte shape(3), that full activity of nonmuscle myosin
requires phosphorylation of the myosin light chain (1), and
that several other cytoskeletal proteins maybe phosphorylated
(4, 27, 34, 37). Theobservation that the product of the src gene
of avian sarcoma virus, which induces ruffling and cell round-
ing in chickfibroblasts (2, 38), is a proteinkinase (10) is further
evidence that cell shape may be regulated by protein phos-
phorylation/dephosphorylation reactions.
Because both the src-coded kinase (20, 11) and the EGF-
stimulated kinase from A-431 cells (35) specifically phospho-
rylate tyrosine, it is possible that phosphorylation of tyrosine
in certain cytoskeletal proteins maybe responsible for ruffling
and rounding induced either by viral transformation or by
EGF.
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